Fieldpoint Private Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$125K Buy
357
+301
+538% +$123K 0.04% 324
2022
Q1
$31K Buy
56
+5
+10% +$2.63K 0.01% 713
2021
Q4
$34K Buy
51
+5
+11% +$3.14K 0.01% 713
2021
Q3
$29K Buy
46
+6
+15% +$4.03K 0.01% 712
2021
Q2
$27K Sell
40
-27
-40% -$14.9K 0.01% 724
2021
Q1
$33K Hold
67
0.01% 661
2020
Q4
$33K Buy
+67
New +$30K 0.01% 558

Other funds holding IDXX

Fieldpoint Private Securities's IDXX Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Idexx Laboratories (IDXX) stake by 538% in Q2 2022, buying an estimated $123K and bringing the position to 357 shares worth $125K. The position accounts for 0.04% of the portfolio, ranked #324.

Fieldpoint Private Securities first reported a position in IDXX in Q4 2020 and has held it in 7 quarters since. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Fieldpoint Private Securities held 357 shares of Idexx Laboratories worth $125K as of Q2 2022.
  • Fieldpoint Private Securities bought 301 Idexx Laboratories shares in Q2 2022, an estimated $123K.
  • Idexx Laboratories made up 0.04% of Fieldpoint Private Securities's portfolio in Q2 2022, its #324 holding.
  • Fieldpoint Private Securities first reported a position in Idexx Laboratories in Q4 2020 and has held it in 7 quarters since.
  • 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.